Trading Ideas Ocugen, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 11:29:21 2024-05-20 am EDT			5-day change	1st Jan Change
1.915 ^USD	+0.26%		+5.25%	+231.30%

May. 15	Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study	MT
May. 15	Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST?A Modifier Gene Therapy	CI

No results for this search